Roche Diagnostics is a company that makes diagnostic tests and medical devices. It lobbies Congress mainly on Medicare and Medicaid rules, seeking coverage and reimbursement for diagnostic tests and for FDA-designated breakthrough devices, including proposals for a temporary transitional coverage period. Its filings show four reports totaling $160,000 and it hired The McManus Group for this work.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
JOHN MCMANUS
The latest disclosures for this client.
THE MCMANUS GROUP
Q2THE MCMANUS GROUP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE MCMANUS GROUP
ALEX WHALEN
THE MCMANUS GROUP
ms LAWREN D GEER
THE MCMANUS GROUP
ABIGAIL SMITH
THE MCMANUS GROUP
ms MARY GRACE DARCEY
THE MCMANUS GROUP
THE MCMANUS GROUP
Q4THE MCMANUS GROUP
Q3THE MCMANUS GROUP
Q2THE MCMANUS GROUP
Q1